The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Hippo Pathway Activity Influences Liver Cell Fate
Open accessAbstract
The Hippo-signaling pathway is an important regulator of cellular proliferation and organ size. However, little is known about the role of this cascade in the control of cell fate. Employing a combination of lineage tracing, clonal analysis, and organoid culture approaches, we demonstrate that Hippo pathway activity is essential for the maintenance of the differentiated hepatocyte state. Remarkably, acute inactivation of Hippo pathway signaling in vivo is sufficient to dedifferentiate, at very high efficiencies, adult hepatocytes into cells bearing progenitor characteristics. These hepatocyte-derived progenitor cells demonstrate self-renewal and engraftment capacity at the single-cell level. We also identify the NOTCH-signaling pathway as a functional important effector downstream of the Hippo transducer YAP. Our findings uncover a potent role for Hippo/YAP signaling in controlling liver cell fate and reveal an unprecedented level of phenotypic plasticity in mature hepatocytes, which has implications for the understanding and manipulation of liver regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following diverse injuries, often involving cholestasis, YAP signalling also drives hepatocyte reprogramming via SOX9 induction.”
From Distinct hepatocyte identities in liver homeostasis and regeneration (2023) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These reprogrammed zone 1 hepatocytes exhibited reduced metabolic function, upregulated tissue stem cell markers and increased proliferative capacity, contributing to regeneration.59,60,100,101”
From Distinct hepatocyte identities in liver homeostasis and regeneration (2023) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Acute YAP overexpression results in hepatocyte reprogramming into BEC10.”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“YAP, the main transducer of the Hippo pathway, has been reported to be necessary and sufficient for hepatocyte reprogramming into ductal cells10,11.”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, increased chromatin accessibility near YAP target genes suggested a pivotal role for YAP/TEAD signaling in the reprogramming process (Figure S1C), supporting previous data10.”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Under physiological conditions, activation of YAP is necessary and sufficient to not only reprogram hepatocytes but to precisely control developmental outcomes, organ size and tissue repair10,16,40,41.”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lineage-tracing studies in animal models have confirmed that hepatocytes contribute to bile duct remodeling following cholangiocyte injury10,43–48”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In periportal injury, LPLCs are mainly generated in the region 1-5 layers away from injured bile ducts.[7][8][9]12,13”
From Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, YAP promotes SRY-box transcription factor 9 (SOX9) expression in hepatocytes59 and may confer the hybrid hepatocyte-biliary identity of periportal SOX9+ hepatocytes.60”
From Distinct hepatocyte identities in liver homeostasis and regeneration (2023) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Hepatocytes display remarkable plasticity and under some conditions can transdifferentiate into BECs, epithelial cells of the bile ducts with completely different morphology, gene expression and function59,[97], [98], [99]”
From Distinct hepatocyte identities in liver homeostasis and regeneration (2023) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Even at this later stage, reprogrammed hepatocytes maintained distinct chromatin accessibility compared to BECs (Figure 1H), despite resembling them morphologically and transcriptionally10 (Figure S1E).”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“only very recent studies using a mosaic YAP1 induction model have shown that nuclear YAP1 is able to induce hepatocyte dedifferentiation into clonogenic progenitors in vivo (Yimlamai et al., 2014).”
From Hippo Signaling Influences HNF4A and FOXA2 Enhancer Switching during Hepatocyte Differentiation (2014) · cites this paper as Yimlamai et al., 2014
In the citing paper
“Further experiments in mice have shown that hepatocytes can change into a biliary ductular phenotype21, 22 then later re-differentiate into hepatocytes23.”
From Hepatic progenitor cells of biliary origin with liver repopulation capacity (2015) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Model-Based Clustering, Discriminant Analysis, and Density Estimation
Fraley, C., & Raftery, A. E. (2002) · Journal of the American Statistical Association · doi:10.1198/016214502760047131 · Cited by 4,274
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Huch, M., Dorrell, C., Boj, S. F., van Es, J. H., Li, V. S. W., van de Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M. J., et al. (2013) · Nature · doi:10.1038/nature11826 · Cited by 1,555
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
Self-citationZhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 937
Furuyama, K., Kawaguchi, Y., Akiyama, H., Horiguchi, M., Kodama, S., Kuhara, T., Hosokawa, S., Elbahrawy, A., Soeda, T., Koizumi, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.722 · Cited by 841
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Hamaratoǧlu, F., Willecke, M., Kango‐Singh, M., Nolo, R. M., Hyun, E., Tao, C., Jafar‐Nejad, H., & Halder, G. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 765
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–846 of 846
Cigliano, A., Zhang, S., Ribback, S., Steinmann, S. M., Sini, M., Ament, C. E., Utpatel, K., Song, X., Wang, J., Pilo, M. G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19980607
Shao, C., Yang, X., Jing, Y., Hou, X., Huang, Y., Zong, C., Gao, L., Liu, W., Jiang, J., Ye, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14767027
Cigliano, A., Zhang, S., Ribback, S., Steinmann, S. M., Sini, M., Ament, C. E., Utpatel, K., Song, X., Wang, J., Pilo, M. G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19980604
Cigliano, A., Zhang, S., Ribback, S., Steinmann, S. M., Sini, M., Ament, C. E., Utpatel, K., Song, X., Wang, J., Pilo, M. G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19980619
Cigliano, A., Zhang, S., Ribback, S., Steinmann, S. M., Sini, M., Ament, C. E., Utpatel, K., Song, X., Wang, J., Pilo, M. G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19980595
Cigliano, A., Zhang, S., Ribback, S., Steinmann, S. M., Sini, M., Ament, C. E., Utpatel, K., Song, X., Wang, J., Pilo, M. G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19980586
Shao, C., Yang, X., Jing, Y., Hou, X., Huang, Y., Zong, C., Gao, L., Liu, W., Jiang, J., Ye, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14767012
Cigliano, A., Zhang, S., Ribback, S., Steinmann, S. M., Sini, M., Ament, C. E., Utpatel, K., Song, X., Wang, J., Pilo, M. G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19980577
Liang, J., Wei, J., Cao, J., Qian, J., Gao, R., Li, X., Wang, D., Gu, Y., Dong, L., Yu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26634351
Shao, C., Yang, X., Jing, Y., Hou, X., Huang, Y., Zong, C., Gao, L., Liu, W., Jiang, J., Ye, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14767024
Cigliano, A., Zhang, S., Ribback, S., Steinmann, S. M., Sini, M., Ament, C. E., Utpatel, K., Song, X., Wang, J., Pilo, M. G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19980592
Shao, C., Yang, X., Jing, Y., Hou, X., Huang, Y., Zong, C., Gao, L., Liu, W., Jiang, J., Ye, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14767015
Aksu, M., Millender, J. T., McCabe, C. E., Watkins, R. D., Yonkus, J. A., Buckarma, E. H., Werneburg, N. W., O’Brien, D. R., Graham, R. P., Gores, G. J., et al. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01133-x
Mechanisms of Liver Regeneration
Kofler, A., Poelsler, L. H., Oberhuber, R., & Primavesi, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-10997-2_1
Bhat, M. A., Mushtaq, I., & Raja, W. Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-23908-3.00007-1
Hu, K., Zhao, Y., Fu, X., Li, S., Wu, T., Liu, W., Wang, W., Cheng, C., Qiu, H., Pan, S., et al. (2026) · Molecular Pharmacology · doi:10.1016/j.molpha.2026.100105
YAP disrupts bile acid homeostasis to drive cancer-associated cachexiaPreprint
Webb, M., Wong, M., Karamalakis, A. P., Liu, Y., Evason, K. J., Sun, K., Brown, K., Black, J. R., Yang, Y., & Cox, A. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.01.702698
NRF2 co-opts the SWI/SNF complex to drive liver cell plasticityPreprint
Ong, A. J. S., Wong, C. C., Karamalakis, A. P., Evason, K. J., Brown, K., & Cox, A. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.09.704724
Recent trends in lipid metabolism research in liver cancer: a bibliometric analysis
Shi, Y., Yang, X., Yu, Y., Bai, Y., Liu, P., Cao, J., & Xie, W. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1704007
USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation
Li, L., Wang, X., Yang, Y., Zhou, Y., Jiang, Z., Zhai, L., Zhao, X., Qiang, H., Luo, J., Ji, Y., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00749-w
Rôle de la voie de signalisation Hippo dans le développement des ostéosarcomes
Morice, S. (2019) · theses.fr (ABES) · doi:10.70675/32829b80z5982z4f52z949bz98b3ed38b7c0
Bousaleh, M. (2019) · theses.fr (ABES) · doi:10.70675/d39b3d1bzaa47z40c1zbde5z90e63b846fc9
Study of septin 9 in the cell polarity and development of cholangiocarcinoma
Cai, T. (2022) · theses.fr (ABES) · doi:10.70675/c3888784z575bz4056z8b60z98cb8e7e8719
Epigenetic characterization of cellular pliancy in breast cancer
Benhassoun, R. (2024) · theses.fr (ABES) · doi:10.70675/0b1d39b2za3d7z4b26zb4b0zaafa77d5068a
Li, L., He, S., Wang, R., Wang, J., Zheng, Z., Wang, Z., Li, B., Ye, W., & Wang, P. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08792-0
Zeng, C., Zhan, X., Xiao, K., & Li, C. (2026) · Biomolecules · doi:10.3390/biom16050642
Advancing hepatocyte-based therapies: A translational perspective
Sun, Z. X., Zhang, L., & Hui, L. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.04.007 · Cited by 1
Developing a Clinically Practical Biomaterial Platform for Endogenous Liver Regeneration
Beamish, C., Abounorinejad, F., Kim, D. K., Tong, A. P., Barri, H., Marx, C., Lane, D., McGregor, H., Laidlaw, G., Jeffries, J., et al. (2026) · Gels · doi:10.3390/gels12050426
The role of Hippo pathway in cancer progression: Implications for cancer stem cells and EMT
Han, X., Wang, L., Li, Y., & Wang, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189621
Yin, D.-Y., Liu, X.-Y., Li, A., & Ren, Z.-G. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.117873
Inflammatory monocytes constrain YAP-induced cell proliferation
Singh, S., Tahmasian, N., Liu, J., Wang, W., Haas, L., Zhu, Y., Griswold, M. M., Brodsky, N. N., Liu, S., Kalish, B. T., et al. (2026) · Science Advances · doi:10.1126/sciadv.aee8580
Self-citationFrom liver organoids to regulatory platforms for precision hepatology: Advances and challenges
Xu, X., Zhuang, C., Liu, Y., Zhang, Y., Fang, Y., Gonzalez, F. J., Yan, T., & Hao, H. (2026) · The Innovation Drug Discovery · doi:10.59717/j.xinn-drugdisc.2026.100026
Synthetic developmental engineering of human liver organogenesis
Taheri, M. N., Xiang, Y., & Ebrahimkhani, M. R. (2026) · Development · doi:10.1242/dev.205040
Kamimura, H., Kamimura, K., & Terai, S. (2026) · Diagnostic Pathology · doi:10.1186/s13000-026-01805-8
Nishida, H., Matsuura, K., & Daa, T. (2026) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000001338
Amicone, L., Cicchini, C., Petti, F., & Marchetti, A. (2026) · Genes · doi:10.3390/genes17080851
Contribution of mechanical forces in multiciliated cell differentiation
Spassky, N., & Delgehyr, N. (2026) · Open Biology · doi:10.1098/rsob.260101
Hirao, H., Adawy, A., Fujiwara, Y., Yoshii, D., Pan, C., Li, L., Yano, H., Kondo, Y., Honda, M., Han, J., et al. (2026) · The Journal of Pathology · doi:10.1002/path.70110
Chen, C., Morecock, C., Wang, Q., Bala, M., Zaman, S. U., Li, J., Liu, J., Boyan, B. D., Winn, R., Chow, L. T., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102433
Zhong, Z., Jin, R., Zhong, Y., Fu, Y., Zhu, R., Zhang, L., Jiao, Z., Zhou, F., Meng, L., Zhu, J., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.006
Lee, V., Chiang, C., Balogun, O., Cornuet, P. K., Carson, M., Aggarwal, R., Case, R., IV, Goel, C., El-Mossier, S. O., Liu, J.-J., et al. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.09.003
Metadata
- Authors
- Yimlamai, D., Christodoulou, C., Galli, G. G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B. Z., & Camargo, F. D.
- Affiliations
- Boston Children's Hospital (US)
- University of Pennsylvania (US)
- Corresponding author
- Camargo, Fernando D.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 157
- Issue
- 6
- Pages
- 1324-1338
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4136468
- OpenAlex
- W2028593002
- Cited by
- 857
- References
- 48
- Citations by year
- 2026: 34 · 2025: 52 · 2024: 62 · 2023: 64 · 2022: 94 · 2021: 82 · 2020: 91 · 2019: 80 · 2018: 79 · 2017: 58 · 2016: 82 · 2015: 57 · 2014: 20
- FWCI
- 36.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (AR064036, DK083355, DK099559)
- American-Italian Cancer Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases (5T32 DK007477-27)
- National Science Foundation (DGE1144152)
- U.S. Department of Defense (W81XWH-9)
- Harvard Stem Cell Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- Hippo signaling pathway, YAP, hepatocyte dedifferentiation, hepatic progenitor cells, Notch signaling, phenotypic plasticity, liver regeneration, hepatocyte differentiation
- MeSH terms
- Hippo Signaling Pathway, YAP-Signaling Proteins, Animals, Liver, Phosphoproteins, Stem Cells, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Hepatocytes, Adaptor Proteins, Signal Transducing, Mice, Receptors, Notch, Cell Dedifferentiation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
